PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ)

CUSIP: 71426V306

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
2,029,466
Share change
+9,810
Total reported value
$4,849,390
Put/Call ratio
118%
Price per share
$2.39
Number of holders
20
Value change
+$22,252
Number of buys
10
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) as of Q1 2018

As of 31 Mar 2018, PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,029,466 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Aisling Capital LLC, BlackRock Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, Cetera Investment Advisers, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.